OnCo

Stay in the loop

Leave your email and OnCo will write when something big changes in cancer research. No spam, one click to unsubscribe.

Email updates open shortly. Until then, press Watch on any page to keep it on your list.

drugsTreatmentApproved

Pixantrone

aka BBR 2778, Pixantrone dimaleate

Pixantrone is an anthracycline-like drug engineered to spare the heart, approved in the European Union in 2012 as a single agent for adults with aggressive B-cell lymphoma that has relapsed several times.